Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 19
2024
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-0.2%
|
$16,731
$169.79 P/Share
|
Dec 19
2024
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39
+0.16%
|
$6,591
$169.79 P/Share
|
Dec 19
2024
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Payment of exercise price or tax liability
|
Direct |
58
-0.42%
|
$9,802
$169.79 P/Share
|
Dec 19
2024
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
BUY
Exercise of conversion of derivative security
|
Direct |
58
+0.42%
|
$9,802
$169.79 P/Share
|
Dec 19
2024
|
Susan Street Whaley Chief Legal Officer & Secy |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-0.18%
|
$5,915
$169.79 P/Share
|
Dec 19
2024
|
Susan Street Whaley Chief Legal Officer & Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
35
+0.18%
|
$5,915
$169.79 P/Share
|
Dec 19
2024
|
Sundar G. Raman CEO-Fabric & Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-0.26%
|
$13,182
$169.79 P/Share
|
Dec 19
2024
|
Sundar G. Raman CEO-Fabric & Home Care |
BUY
Exercise of conversion of derivative security
|
Direct |
78
+0.26%
|
$13,182
$169.79 P/Share
|
Dec 19
2024
|
Marc S. Pritchard Chief Brand Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
77
-0.04%
|
$13,013
$169.79 P/Share
|
Dec 19
2024
|
Marc S. Pritchard Chief Brand Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
77
+0.04%
|
$13,013
$169.79 P/Share
|
Dec 19
2024
|
Andre Schulten Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
70
-0.2%
|
$11,830
$169.79 P/Share
|
Dec 19
2024
|
Andre Schulten Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70
+0.19%
|
$11,830
$169.79 P/Share
|
Dec 19
2024
|
Balaji Purushothaman Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31
-0.27%
|
$5,239
$169.79 P/Share
|
Dec 19
2024
|
Balaji Purushothaman Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31
+0.27%
|
$5,239
$169.79 P/Share
|
Dec 19
2024
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-0.46%
|
$7,774
$169.79 P/Share
|
Dec 19
2024
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46
+0.46%
|
$7,774
$169.79 P/Share
|
Dec 19
2024
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5
-0.69%
|
$845
$169.79 P/Share
|
Dec 19
2024
|
Jennifer L. Davis CEO - Health Care |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-0.09%
|
$7,774
$169.79 P/Share
|
Dec 19
2024
|
Jennifer L. Davis CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
46
+0.09%
|
$7,774
$169.79 P/Share
|
Dec 19
2024
|
Jon R Moeller Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,317
-0.16%
|
$222,573
$169.79 P/Share
|
Dec 19
2024
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
138
+0.05%
|
$23,322
$169.79 P/Share
|
Dec 10
2024
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
175
+0.35%
|
-
|
Dec 10
2024
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
211
+0.5%
|
-
|
Dec 10
2024
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
218
+1.53%
|
-
|
Dec 10
2024
|
Ashley Mc Evoy Director |
BUY
Grant, award, or other acquisition
|
Direct |
175
+5.08%
|
-
|
Dec 10
2024
|
Robert Jones Portman Director |
BUY
Grant, award, or other acquisition
|
Direct |
44
+1.35%
|
-
|
Dec 10
2024
|
Bertrand Marc Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
175
+1.85%
|
-
|
Dec 10
2024
|
M. Brett Biggs Director |
BUY
Grant, award, or other acquisition
|
Direct |
175
+4.45%
|
-
|
Dec 10
2024
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
276
+0.83%
|
-
|
Dec 10
2024
|
Christopher J Kempczinski Director |
BUY
Grant, award, or other acquisition
|
Direct |
175
+2.02%
|
-
|
Nov 27
2024
|
Gary A Coombe CEO - Grooming |
SELL
Open market or private sale
|
Direct |
47,847
-54.48%
|
$8,564,613
$179.84 P/Share
|
Nov 27
2024
|
Gary A Coombe CEO - Grooming |
BUY
Exercise of conversion of derivative security
|
Direct |
47,847
+35.27%
|
$4,354,077
$91.07 P/Share
|
Nov 21
2024
|
Balaji Purushothaman Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,800
-52.47%
|
$2,201,600
$172.73 P/Share
|
Nov 21
2024
|
Balaji Purushothaman Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,800
+34.41%
|
$1,164,800
$91.07 P/Share
|
Oct 24
2024
|
Balaji Purushothaman Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,800
-52.53%
|
$2,150,400
$168.99 P/Share
|
Oct 24
2024
|
Balaji Purushothaman Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,800
+34.44%
|
$1,164,800
$91.07 P/Share
|
Oct 23
2024
|
R. Alexandra Keith CEO - Beauty |
SELL
Discretionary transaction
|
Indirect |
1,365
-18.99%
|
$230,685
$169.49 P/Share
|
Oct 22
2024
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
409
-10.5%
|
$69,530
$170.0 P/Share
|
Oct 22
2024
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
1,992
-12.63%
|
$338,640
$170.0 P/Share
|
Oct 08
2024
|
Amy Chang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+7.98%
|
-
|
Oct 08
2024
|
Rajesh Subramaniam Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+22.32%
|
-
|
Oct 08
2024
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+2.57%
|
-
|
Oct 08
2024
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+8.71%
|
-
|
Oct 08
2024
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+3.06%
|
-
|
Oct 08
2024
|
Ashley Mc Evoy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+29.81%
|
-
|
Oct 08
2024
|
Robert Jones Portman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+29.34%
|
-
|
Oct 08
2024
|
M. Brett Biggs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+26.88%
|
-
|
Oct 08
2024
|
Sheila Bonini Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+31.35%
|
-
|
Oct 08
2024
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+3.88%
|
-
|
Oct 08
2024
|
Christopher J Kempczinski Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+13.7%
|
-
|